-
1
-
-
84905673451
-
-
USAMRU-K. USAMRU-K Public Website, [updated 2013; cited 2014 10 June]; Available from
-
USAMRU-K. USAMRU-K Public Website. 2013 [updated 2013; cited 2014 10 June]; Available from: http://www.usamrukenya. org/.
-
(2013)
-
-
-
3
-
-
79959748626
-
-
Attorney General. Nairobi: National Council for Law Reporting, 2010
-
Attorney General. The Constitution of Kenya, 2010. Nairobi: National Council for Law Reporting, 2010.
-
(2010)
The Constitution of Kenya
-
-
-
4
-
-
79959517599
-
-
Kenya National Bureau of S. Kenya 2008-09: results from the demographic and health survey
-
Kenya National Bureau of S. Kenya 2008-09: results from the demographic and health survey. Stud Fam Plann 2010; 42:131-6.
-
(2010)
Stud Fam Plann
, vol.42
, pp. 131-136
-
-
-
5
-
-
84865778034
-
Profile: The KEMRI/ CDC Health and Demographic Surveillance System-Western Kenya
-
Odhiambo FO, Laserson KF, Sewe M et al. Profile: The KEMRI/ CDC Health and Demographic Surveillance System-Western Kenya. Int J Epidemiol 2012;41:977-87.
-
(2012)
Int J Epidemiol
, vol.41
, pp. 977-987
-
-
Odhiambo, F.O.1
Laserson, K.F.2
Sewe, M.3
-
6
-
-
84871037616
-
A phase 3 trial of RTS,S/ AS01 malaria vaccine in African infants
-
Agnandji ST, Lell B, Fernandes JF et al. A phase 3 trial of RTS,S/ AS01 malaria vaccine in African infants. N Engl J Med 2012;367:2284-95.
-
(2012)
N Engl J Med
, vol.367
, pp. 2284-2295
-
-
Agnandji, S.T.1
Lell, B.2
Fernandes, J.F.3
-
7
-
-
84872569519
-
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
-
Otsyula N, Angov E, Bergmann-Leitner E et al. Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01. Malar J 2013;12:29.
-
(2013)
Malar J
, vol.12
, pp. 29
-
-
Otsyula, N.1
Angov, E.2
Bergmann-Leitner, E.3
-
8
-
-
61849177531
-
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya
-
Ogutu BR, Apollo OJ, McKinney D et al. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 2009;4:e4708.
-
(2009)
PLoS One
, vol.4
-
-
Ogutu, B.R.1
Apollo, O.J.2
McKinney, D.3
-
9
-
-
68149092706
-
Evaluation of RTS,S/ AS02A and RTS.S/AS01B in adults in a high malaria transmission area
-
Polhemus ME, Remich SA, Ogutu BR et al. Evaluation of RTS,S/ AS02A and RTS,S/AS01B in adults in a high malaria transmission area. PLoS One 2009;4:e6465.
-
(2009)
PLoS One
, vol.4
-
-
Polhemus, M.E.1
Remich, S.A.2
Ogutu, B.R.3
-
10
-
-
56549110631
-
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial
-
Abdulla S, Sagara I, Borrmann S et al. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet 2008;372:1819-27.
-
(2008)
Lancet
, vol.372
, pp. 1819-1827
-
-
Abdulla, S.1
Sagara, I.2
Borrmann, S.3
-
11
-
-
70350031257
-
Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
-
Abdulla S, Sagara I. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children. Malar J 2009;8(Suppl 1):S7.
-
(2009)
Malar J
, vol.8
, Issue.SUPPL. 1
-
-
Abdulla, S.1
Sagara, I.2
-
12
-
-
84897870237
-
Association between Sickle Cell Trait and Low Density Parasitaemia in a P. falciparum Malaria Holoendemic Region of Western Kenya
-
Otieno W, Estambale B, Aluoch JR, et al. Association between Sickle Cell Trait and Low Density Parasitaemia in a P. falciparum Malaria Holoendemic Region of Western Kenya. IJTDH. 2012;2:231-40
-
(2012)
IJTDH
, vol.2
, pp. 231-240
-
-
Otieno, W.1
Estambale, B.2
Aluoch, J.R.3
-
13
-
-
84899052583
-
The Kenya AIDS indicator survey 2012: rationale, methods, description of participants, and response rates
-
Waruiru W, Kim AA, Kimanga DO et al. The Kenya AIDS indicator survey 2012: rationale, methods, description of participants, and response rates. J Acquir Immune Defic Syndr 2014;66(Suppl 1):S3-S12.
-
(2014)
J Acquir Immune Defic Syndr
, vol.66
, Issue.SUPPL. 1
-
-
Waruiru, W.1
Kim, A.A.2
Kimanga, D.O.3
-
14
-
-
84905645982
-
-
Indepthnetwork. website [updated 2014; cited 2014 13 May]; Available from
-
Indepthnetwork. website. 2003 [updated 2014; cited 2014 13 May]; Available from: http://www.indepthnetwork.org/.
-
(2003)
-
-
|